Last edition
News about "Emcure Pharmaceuticals Limited"
Emcure's Sanand Manufacturing Facility Clears US FDA Inspection With Zero Observations
The PAI, held between June 30 and July 8, 2025, is a critical regulatory step for pharmaceutical companies seeking approval to launch new products in the US. It assesses a manufacturing site’s adherence to Good Manufacturing Practices (GMP) and overall readiness to support a pending New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Emcure Pharmaceuticals Limited | 10/07/2025 | By Darshana | 145
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy